124 related articles for article (PubMed ID: 21878740)
1. Decreased expression of intestinal P-glycoprotein increases the analgesic effects of oral morphine in a streptozotocin-induced diabetic mouse model.
Nawa A; Fujita-Hamabe W; Kishioka S; Tokuyama S
Drug Metab Pharmacokinet; 2011; 26(6):584-91. PubMed ID: 21878740
[TBL] [Abstract][Full Text] [Related]
2. [Altered intestinal P-glycoprotein expression levels affect pharmacodynamics under diabetic condition].
Nawa A; Fujita-Hamabe W; Kisioka S; Tokuyama S
Yakugaku Zasshi; 2012; 132(2):161-6. PubMed ID: 22293693
[TBL] [Abstract][Full Text] [Related]
3. Involvement of ubiquitination in the decrease of intestinal P-glycoprotein in a streptozotocin-induced diabetic mouse model.
Nawa A; Fujita-Hamabe W; Tokuyama S
Drug Metab Pharmacokinet; 2012; 27(5):548-52. PubMed ID: 22498644
[TBL] [Abstract][Full Text] [Related]
4. [Nitric oxide synthase-mediated alteration of intestinal P-glycoprotein under hyperglycemic stress].
Nawa A; Fujita-Hamabe W; Nakamoto K; Tokuyama S
Yakugaku Zasshi; 2011 Apr; 131(4):487-92. PubMed ID: 21467785
[TBL] [Abstract][Full Text] [Related]
5. Decreased analgesic effect of morphine, but not buprenorphine, in patients with advanced P-glycoprotein(+) cancers.
Wang J; Cai B; Huang DX; Yang SD; Guo L
Pharmacol Rep; 2012; 64(4):870-7. PubMed ID: 23087138
[TBL] [Abstract][Full Text] [Related]
6. Inducible nitric oxide synthase-mediated decrease of intestinal P-glycoprotein expression under streptozotocin-induced diabetic conditions.
Nawa A; Fujita Hamabe W; Tokuyama S
Life Sci; 2010 Mar; 86(11-12):402-9. PubMed ID: 20097209
[TBL] [Abstract][Full Text] [Related]
7. Etoposide modulates the effects of oral morphine analgesia by targeting the intestinal P-glycoprotein.
Fujita-Hamabe W; Nishida M; Nawa A; Kobori T; Nakamoto K; Kishioka S; Tokuyama S
J Pharm Pharmacol; 2012 Apr; 64(4):496-504. PubMed ID: 22420656
[TBL] [Abstract][Full Text] [Related]
8. Negative relationship between morphine analgesia and P-glycoprotein expression levels in the brain.
Hamabe W; Maeda T; Kiguchi N; Yamamoto C; Tokuyama S; Kishioka S
J Pharmacol Sci; 2007 Dec; 105(4):353-60. PubMed ID: 18071274
[TBL] [Abstract][Full Text] [Related]
9. Regulatory action of nitric oxide synthase on ileal P-glycoprotein expression under streptozotocin-induced diabetic condition.
Nawa A; Fujita-Hamabe W; Tokuyama S
Biol Pharm Bull; 2011; 34(3):436-8. PubMed ID: 21372399
[TBL] [Abstract][Full Text] [Related]
10. RhoA affects oral morphine analgesia depending on functional variation in intestinal P-glycoprotein induced by repeated etoposide treatment.
Kobori T; Kobayashi M; Harada S; Nakamoto K; Fujita-Hamabe W; Tokuyama S
Eur J Pharm Sci; 2012 Dec; 47(5):934-40. PubMed ID: 22982667
[TBL] [Abstract][Full Text] [Related]
11. [Effect of repeated oral treatment with etoposide on the expression of intestinal P-glycoprotein and oral morphine analgesia].
Kobori T; Harada S; Nakamoto K; Tokuyama S
Yakugaku Zasshi; 2014; 134(6):689-99. PubMed ID: 24882643
[TBL] [Abstract][Full Text] [Related]
12. Altered intestinal P-glycoprotein expression levels in a monosodium glutamate-induced obese mouse model.
Nawa A; Fujita-Hamabe W; Tokuyama S
Life Sci; 2011 Dec; 89(23-24):834-8. PubMed ID: 21983297
[TBL] [Abstract][Full Text] [Related]
13. Role of nitric oxide in diabetes-induced attenuation of antinociceptive effect of morphine in mice.
Grover VS; Sharma A; Singh M
Eur J Pharmacol; 2000 Jul; 399(2-3):161-4. PubMed ID: 10884515
[TBL] [Abstract][Full Text] [Related]
14. Tissue-specific alterations in expression and function of P-glycoprotein in streptozotocin-induced diabetic rats.
Zhang LL; Lu L; Jin S; Jing XY; Yao D; Hu N; Liu L; Duan R; Liu XD; Wang GJ; Xie L
Acta Pharmacol Sin; 2011 Jul; 32(7):956-66. PubMed ID: 21685928
[TBL] [Abstract][Full Text] [Related]
15. Attenuation of morphine tolerance and dependence by aminoguanidine in mice.
Abdel-Zaher AO; Hamdy MM; Aly SA; Abdel-Hady RH; Abdel-Rahman S
Eur J Pharmacol; 2006 Jul; 540(1-3):60-6. PubMed ID: 16730698
[TBL] [Abstract][Full Text] [Related]
16. The interaction between IL-1beta and morphine: possible mechanism of the deficiency of morphine-induced analgesia in diabetic mice.
Gul H; Yildiz O; Dogrul A; Yesilyurt O; Isimer A
Pain; 2000 Dec; 89(1):39-45. PubMed ID: 11113291
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of iNOS alleviates cognitive deficits and depression in diabetic mice through downregulating the NO/sGC/cGMP/PKG signal pathway.
Zhou XY; Zhang F; Ying CJ; Chen J; Chen L; Dong J; Shi Y; Tang M; Hu XT; Pan ZH; Xu NN; Zheng KY; Tang RX; Song YJ
Behav Brain Res; 2017 Mar; 322(Pt A):70-82. PubMed ID: 28077315
[TBL] [Abstract][Full Text] [Related]
18. Modulation by alpha-difluoromethyl-ornithine and aminoguanidine of pain threshold, morphine analgesia and tolerance.
Lu G; Su RB; Li J; Qin BY
Eur J Pharmacol; 2003 Oct; 478(2-3):139-44. PubMed ID: 14575798
[TBL] [Abstract][Full Text] [Related]
19. Narcotics and diabetes. I. The effects of streptozotocin-induced diabetes on the antinociceptive potency of morphine.
Simon GS; Dewey WL
J Pharmacol Exp Ther; 1981 Aug; 218(2):318-23. PubMed ID: 7019415
[TBL] [Abstract][Full Text] [Related]
20. Oxcarbazepine antinociception in animals with inflammatory pain or painful diabetic neuropathy.
Kiguchi S; Imamura T; Ichikawa K; Kojima M
Clin Exp Pharmacol Physiol; 2004; 31(1-2):57-64. PubMed ID: 14756685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
